|
Volumn 87, Issue 12, 2002, Pages
|
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
IMATINIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADJUVANT THERAPY;
ADULT;
ARTICLE;
CASE REPORT;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
REMISSION;
SALVAGE THERAPY;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
FUSION PROTEINS, BCR-ABL;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L2;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PIPERAZINES;
PYRIMIDINES;
RADIOTHERAPY, ADJUVANT;
REMISSION INDUCTION;
SALVAGE THERAPY;
TRANSPLANTATION CONDITIONING;
|
EID: 1642331267
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|